Pathologic comparison of laparoscopic versus open radical retropubic prostatectomy specimens

Brown, James A.; Garlitz, Christopher; Gomella, Leonard G.; Hubosky, Scott G.; Diamond, Stuart M.; McGinnis, David E.; Strup, Stephen E.

doi:10.1016/s0090-4295(03)00387-x

Cited by 48 publications

(28 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our PSM rates (pT2, 17.1%; pT3a, 44.4%; pT3b, 50.0%) were comparable, although we acknowledge the fact that the patients in our series were of better preoperative stage and the follow-up so far has been a brief period of time. Fromont et al [31] reported a significant reduction of PSM in LRP, and LRP was also reported to have lower PSM rates at apex and multiple sites [32].…”

Section: Discussionmentioning

confidence: 99%

Laparoscopic radical prostatectomy: oncological and functional results of 126 patients with a minimum 3-year follow-up at a single Chinese institute

Gao¹,

Zhou²,

Li³

et al. 2009

Asian J Androl

View full text Add to dashboard Cite

In this study we evaluate the oncological and functional results of the largest cohort of patients in China treated by laparoscopic radical prostatectomy (LRP) and with at least 3 years of follow-up. 126 inconsecutive patients (range 56-78 years, median 62.5) who had an LRP were retrospectively analyzed. The mean prostate specific antigen level and Gleason score was 13.4 ng mL -1 and 6.4, respectively. Twenty-seven patients had unilateral or bilateral nerve preservation and 29 had pelvic lymphadenectomy. Multivariate analysis was used to adjust for differences in clinical and pathological features when comparing the risk for biochemical progression-free survival (bPFS). Urinary continence was assessed by incontinence questionnaire and erectile function by the Sexual Health Inventory for Men score. The mean operative duration was 250 min and blood loss 354 mL. Five patients received blood transfusion and nine had complications, including rectal injury (two), ureteral injury (one), active bleeding (one), bladder neck stenosis (two), paralytic ileus (one), subcutaneous hematoma (one) and port-site hernia (one). The overall positive surgical margin rate was 20.6% and correlated with pathological stage and Gleason score respectively (P = 0.03, P < 0.001 respectively). All patients had ≥ 3 years of follow-up (range 3-6.75 years, mean 4.6, median 4.75). At 3 years of follow-up, the overall survival rate was 100% and the bPFS was 81.0% in all patients; 124 patients (98.4%) were continent; 22 of 27 patients (81.5%) who underwent nerve preservation retained erectile function. Our series confirms that LRP is an effective, safe and precise technique at Chinese institution.

show abstract

Section: Discussionmentioning

confidence: 99%

Laparoscopic radical prostatectomy: oncological and functional results of 126 patients with a minimum 3-year follow-up at a single Chinese institute

Gao¹,

Zhou²,

Li³

et al. 2009

Asian J Androl

View full text Add to dashboard Cite

show abstract

“…82, [151][152][153] Concerning established key features of quality-assured pathological examination, 19 (79%) studies described preliminary dyeing of the surface of the prostate to accurately identify the location of the surgical margin. The accepted definition of a positive margin in terms of tumour cells touching or in contact with the dyed prostate surface was specified by 18 (75%) studies; alternative descriptions used were 'an extension of tumour at the surface of incision' 141 and 'a malignant margin is considered a positive margin' , 138 but these studies did not comment on whether or not the specimen was dyed before sectioning.…”

Section: Figurementioning

confidence: 99%

Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.

Ramsay

Pickard²,

Robertson³

et al. 2012

Health Technol Assess

171

166

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeThe Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service' . The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projec...

show abstract

“…All in all 17% of the LRP and 20% of the RRP specimens from each cohort had positive inked margins, but the LRP specimens had a lower rate of apex and multiple-site positive margins (18).…”

Section: Comparison Between Lrp and Rrpmentioning

confidence: 85%

“…Because it is a novel technique, randomized studies are not yet available. Anyway, some comparative retrospective studies and recently some prospective although non-randomized studies have already been published which provide accurate data collection and thus an adequate level of evidence (12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22).…”

Section: Comparison Between Lrp and Rrpmentioning

confidence: 99%

Laparoscopic radical prostatectomy: A European virus

Skrekas

Laguna

Rosette

2005

Minimally Invasive Therapy & Allied Technologies

View full text Add to dashboard Cite

The evolution of prostate cancer treatment has now incorporated the principles of minimally invasive surgery. Laparoscopic radical prostatectomy, just like a virus, infected first Europe and three years ago the United States. This European virus has nowadays a potentially widespread application. Oncological efficacy and ability to preserve and improve continence and potency are the factors that will ultimately determine the role of laparoscopic radical prostatectomy and thus the future of this virus infection. This article reviews the current published experience with minimally invasive prostatectomy and provides comparisons to published data on radical retropubic prostatectomy to increase awareness about viability. Some prospective and retrospective non-randomized comparative studies of the two approaches are also included in the present review. The current practice patterns regarding urological laparoscopic surgery and the tendency of the urologic community in Europe and in the United States to establish minimally invasive radical prostatectomy in more urological departments are described.

show abstract

Pathologic comparison of laparoscopic versus open radical retropubic prostatectomy specimens

Cited by 48 publications

References 10 publications

Laparoscopic radical prostatectomy: oncological and functional results of 126 patients with a minimum 3-year follow-up at a single Chinese institute

Laparoscopic radical prostatectomy: oncological and functional results of 126 patients with a minimum 3-year follow-up at a single Chinese institute

Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.

Laparoscopic radical prostatectomy: A European virus

Contact Info

Product

Resources

About